SCZD
MCID: SCH015
MIFTS: 77

Schizophrenia (SCZD) malady

Categories: Genetic diseases, Mental diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Schizophrenia

About this section

Aliases & Descriptions for Schizophrenia:

Name: Schizophrenia 52 35 11 24 25 70 27 12 50 38 39 13 68
Schizoaffective Disorder 52 11 70 50 13 68
Schizophrenia 12 52 12 68
Schizophrenia 9 70 27 68
Schizophrenia 6 27 68
Schizophrenia Susceptibility Locus Chromosome 1q-Related 70
 
Schizophrenia, Susceptibility to 12
Dementia Praecox 25
Schizophrenia-1 11
Schizophrenia 1 68
Sczd9 70
Sczd 70

Characteristics:

HPO:

64

Classifications:



Summaries for Schizophrenia

About this section
MedlinePlus:38 Schizophrenia is a serious brain illness. people who have it may hear voices that aren't there. they may think other people are trying to hurt them. sometimes they don't make sense when they talk. the disorder makes it hard for them to keep a job or take care of themselves. symptoms of schizophrenia usually start between ages 16 and 30. men often develop symptoms at a younger age than women. people usually do not get schizophrenia after age 45. there are three types of symptoms: psychotic symptoms distort a person's thinking. these include hallucinations (hearing or seeing things that are not there), delusions (beliefs that are not true), trouble organizing thoughts, and strange movements. "negative" symptoms make it difficult to show emotions and to function normally. a person may seem depressed and withdrawn. cognitive symptoms affect the thought process. these include trouble using information, making decisions, and paying attention. no one is sure what causes schizophrenia. your genes, environment, and brain chemistry may play a role. there is no cure. medicine can help control many of the symptoms. you may need to try different medicines to see which works best. you should stay on your medicine for as long as your doctor recommends. additional treatments can help you deal with your illness from day to day. these include therapy, family education, rehabilitation, and skills training. nih: national institute of mental health

MalaCards based summary: Schizophrenia, also known as schizoaffective disorder, is related to personality disorder and hereditary multiple exostoses, and has symptoms including fatigue, fatigue and sleep disturbances. An important gene associated with Schizophrenia is DISC1 (Disrupted In Schizophrenia 1), and among its related pathways is Monoamine GPCRs. The drugs fluphenazine and mesoridazine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and prefrontal cortex, and related mouse phenotypes are Decreased shRNA abundance (Z-score < -2) and behavior/neurological.

Disease Ontology:11 A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness.

Genetics Home Reference:25 Schizophrenia is a mental health disorder classified as a psychosis, which means that it affects a person's thinking, sense of self, and perceptions. The disorder typically appears during late adolescence or early adulthood.

OMIM:52 Schizophrenia is a psychosis, a disorder of thought and sense of self. Although it affects emotions, it is... (181500) more...

UniProtKB/Swiss-Prot:70 Schizophrenia: A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder.

Wikipedia:71 Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand... more...

Descriptions from OMIM:52 604906,603013

Related Diseases for Schizophrenia

About this section

Diseases in the Schizophrenia family:

Schizophrenia 17 Schizophrenia 16
Schizophrenia 10 Schizophrenia 4
Schizophrenia 15 Early-Onset Schizophrenia

Diseases related to Schizophrenia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 328)
idRelated DiseaseScoreTop Affiliating Genes
1personality disorder31.4COMT, DISC1, DRD2, DRD3, DTNBP1, HTR2A
2hereditary multiple exostoses29.8COMT, DRD2, HTR2A
3paranoid schizophrenia12.5
4schizophrenia 412.2
5schizophrenia 1712.1
6schizophrenia 1512.1
7early-onset schizophrenia12.1
8schizophrenia susceptibility 1812.1
9childhood-onset schizophrenia12.0
10schizophrenia 1011.8
11schizophrenia 1611.8
12schizophrenia mental retardation deafness retinitis11.7
13schizophreniform disorder11.3
14psychotic disorder11.1
15neuroleptic malignant syndrome11.1
16darier disease11.0
17landau-kleffner syndrome10.9
18brain glioblastoma multiforme10.8COMT, DAOA, DISC1, DRD2, DRD3, DTNBP1
19chronic conjunctivitis10.8COMT, DAOA, DISC1, DRD2, DRD3, DTNBP1
20syngap1-related non-syndromic intellectual disability10.7
21dopamine beta-hydroxylase deficiency10.7
22hyperprolinemia, type i10.7
23chromosome 15q13.3 microdeletion syndrome10.7
24social emotional agnosia10.7
25chromosome 1q21.1 deletion syndrome10.7
26paraphilia disorder10.7COMT, DISC1, DRD2, DRD3, HTR2A, MTHFR
27bipolar disorder10.6
28primary angle-closure glaucoma10.6COMT, DAO, DTNBP1, HTR2A, NRG1
29benign epilepsy with centrotemporal spikes10.6COMT, DAOA, DISC1, DRD2, HTR2A
30chondrodysplasia lethal recessive10.6COMT, DAOA, NRG1, PRODH
31delusional disorder10.6
32cytomegalic congenital adrenal hypoplasia10.6COMT, DRD2, DRD3, HTR2A
33cecal benign neoplasm10.6COMT, DRD2, DRD3, HTR2A
34retinoblastoma10.6COMT, DRD2, DRD3, HTR2A
35schizotypal personality disorder10.6
36rhinoscleroma10.6COMT, DRD2, NRG1
37teratoma with malignant transformation10.6DRD2, DRD3, HTR2A
38microcephaly 13, primary, autosomal recessive10.6DRD2, DRD3, HTR2A, MTHFR
39pyromania10.5DRD2, DRD3, HTR2A
40ellis-van creveld syndrome10.5COMT, DRD2, DRD3, HTR2A
41c8 deficiency, type ii10.5COMT, DRD2, DRD3
42preeclampsia/eclampsia 510.5COMT, DRD2, DRD3, HTR2A
43hypertrophic olivary degeneration10.5COMT, PRODH
44basal cell carcinoma 310.5COMT, DRD2, HTR2A
45hepatitis d10.4COMT, DRD2, HTR2A
46tardive dyskinesia10.4
47nephronophthisis 1310.4COMT, HTR2A
48neuronitis10.3
49sphenoorbital meningioma10.3DRD2, DRD3
50mood disorder10.2

Comorbidity relations with Schizophrenia via Phenotypic Disease Network (PDN):


Parkinson Disease, Late-OnsetAlzheimer Disease
Deficiency AnemiaBipolar Disorder
Respiratory FailureSchizophreniform Disorder
Heart DiseaseIron Deficiency Anemia
Protein-Energy MalnutritionParanoid Schizophrenia
Acute CystitisHypothyroidism
Active Peptic Ulcer DiseaseDecubitus Ulcer
Tardive Dyskinesia

Graphical network of the top 20 diseases related to Schizophrenia:



Diseases related to schizophrenia

Symptoms & Phenotypes for Schizophrenia

About this section

Symptoms by clinical synopsis from OMIM:

181500

Clinical features from OMIM:

181500,604906,603013

Human phenotypes related to Schizophrenia:

 64 (show all 14)
id Description HPO Frequency HPO Source Accession
1 hallucinations64 HP:0000738
2 delusions64 HP:0000746
3 eeg abnormality64 HP:0002353
4 social and occupational deterioration64 HP:0007086
5 schizophrenia64 HP:0100753
6 ectopic kidney64 HP:0000086
7 renal agenesis64 HP:0000104
8 hypertelorism64 HP:0000316
9 protruding ear64 HP:0000411
10 frontal bossing64 HP:0002007
11 short stature64 HP:0004322
12 flat occiput64 HP:0005469
13 partially duplicated kidney64 HP:0008738
14 short proximal phalanx of the 4th toe64 HP:0100396

UMLS symptoms related to Schizophrenia:


fatigue, sleep disturbances, photophobia, personality changes, restlessness, pseudobulbar behavioral symptoms

GenomeRNAi Phenotypes related to Schizophrenia according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-8411.5CHI3L1, DRD2, TAAR6

MGI Mouse Phenotypes related to Schizophrenia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538612.0COMT, DAO, DISC1, DRD2, DRD3, DTNBP1
2MP:000363111.2COMT, DAO, DISC1, DRD2, DRD3, DTNBP1

Drugs & Therapeutics for Schizophrenia

About this section

Drugs for Schizophrenia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 687)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Minocyclineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 123110118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline HCl
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
NCGC00178854-01
NSC 141993
NSC141993
Novo-Minocycline
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
2
Modafinilapproved, investigationalPhase 4, Phase 2, Phase 1, Early Phase 119768693-11-84236
Synonyms:
2-((diphenylmethyl)sulfinyl)acetamide
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
 
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
3
Paroxetineapproved, investigationalPhase 4, Phase 3, Phase 122861869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
4
Chlorpromazineapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 11850-53-32726
Synonyms:
10-(3-Dimethylaminopropyl)-2-chlorophenothiazine
10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+)
2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine
2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine
2-Chloropromazine
2-Cloro-10 (3-dimetilaminopropil)fenotiazina
2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]
2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine
2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine
2601A
3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine
3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine
34468-21-8
4560 R.P
4560 R.P.
4560 Rp hydrochloride
50-53-3
AB00051943
AC1L1EBT
AKOS001490972
Aminasine
Aminazin
Aminazine
Ampliactil
Amplicitil
Amplictil
BAS 00010434
BC 135
BPBio1_000273
BPBio1_001181
BSPBio_000247
BSPBio_002011
Bio1_000457
Bio1_000946
Bio1_001435
Biomol-NT_000020
C06906
C17H19ClN2S
CAS-69-09-0
CCRIS 3711
CHEBI:3647
CHEMBL71
CID2726
CPZ
Chlor-PZ
Chlor-Promanyl
Chlordelazine
Chlorderazin
Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine
Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]
Chloropromazine
Chlorpromados
Chlorpromanyl
Chlorpromanyl (discontinued)
Chlorpromanyl-20
Chlorpromanyl-40
Chlorpromazin
Chlorpromazine
Chlorpromazine (USP/INN)
Chlorpromazine Hydrochloride Intensol
Chlorpromazine Tannate
Chlorpromazine [USAN:INN:BAN]
Chlorpromazinum
Chlorpromazinum [INN-Latin]
Clorpromazina
Clorpromazina [INN-Spanish]
Clorpromazina [Italian]
Contomin
Cromedazine
D00270
DB00477
DivK1c_000624
EINECS 200-045-8
Elmarin
Esmind
Fenactil
Fenaktyl
Fraction AB
HL 5746
HMS1920M03
HMS2089C12
HMS2091E06
HMS501P06
HSDB 3033
 
I14-6226
IDI1_000624
JHICC02042
KBio1_000624
KBio2_000622
KBio2_002312
KBio2_003190
KBio2_004880
KBio2_005758
KBio2_007448
KBio3_001231
KBio3_002792
KBioGR_000806
KBioGR_002312
KBioSS_000622
KBioSS_002314
L000182
LS-105361
Largactil
Largactil Liquid
Largactil Oral Drops
Largactilothiazine
Largactyl
Lopac-C-8138
Lopac0_000249
Megaphen
MolPort-001-727-953
N-(3-Dimethylaminopropyl)-3-chlorophenothiazine
NCGC00015273-01
NCGC00015273-02
NCGC00015273-03
NCGC00015273-14
NCGC00024409-04
NCGC00024409-05
NCGC00024409-06
NCGC00024409-07
NCGC00024409-08
NINDS_000624
NSC 167745
NSC167745
NSC17479
Novo-Chlorpromazine
Novomazina
Oprea1_110255
Phenactyl
Phenathyl
Phenothiazine hydrochloride
Plegomasine
Plegomazin
Prazilpromactil
Prestwick0_000064
Prestwick1_000064
Prestwick2_000064
Prestwick3_000064
Proma
Promactil
Promazil
Propaphen
Propaphenin
Prozil
Psychozine
QTL1_000021
SKF 2601-A
SKF 2601A
SKF-2601
SPBio_001111
SPBio_002168
SPECTRUM1500184
SR-01000000012-5
STK182870
STOCK1S-46588
Sanopron
Spectrum2_001156
Spectrum3_000346
Spectrum4_000283
Spectrum5_000717
Spectrum_000142
Thorazine
Thorazine (TN)
Thorazine Spansule
Thorazine Suppositories
Thorazine hydrochloride
Torazina
UNII-U42B7VYA4P
WLN: T C666 BN ISJ B3N1&1 EG
Wintermin
Z80
[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine
cMAP_000017
chlorpromazine
5
NorepinephrineapprovedPhase 4, Phase 369951-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
6
MethyltestosteroneapprovedPhase 456358-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
7
AsenapineapprovedPhase 4, Phase 3, Phase 2, Phase 15485650-56-2, 65576-45-63001386
Synonyms:
135882-95-0
1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-met
5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3-6,7)oxepino(4,5-c)pyrrole
65576-45-6
AC1L4SHR
Asenapi
Asenapine
Asenapine [INN:BAN]
CHEMBL504548
 
CID163091
EINECS 265-829-4
I14-8821
Org 5222
Org-5222
PDSP1_001600
PDSP2_001584
Saphris
UNII-JKZ19V908O
[13C,2H3]-Asenipine
trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole
8
Armodafinilapproved, investigationalPhase 4, Phase 2, Phase 1, Early Phase 1197112111-43-0
Synonyms:
 
(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
R-modafinil
9
Guanfacineapproved, investigationalPhase 4, Phase 25929110-47-23519
Synonyms:
29110-47-2
29110-48-3 (mono-hydrochloride)
AC1L1G4B
BPBio1_000415
BRD-K32830106-003-03-0
BSPBio_000377
C07037
C9H9Cl2N3O
CAS-29110-48-3
CHEMBL862
CID3519
D08031
DB01018
EINECS 249-442-8
Estulic
Estulic (TN)
G1043_SIGMA
GUANFACINE
Guanfacina
Guanfacina [INN-Spanish]
Guanfacine (INN)
Guanfacine Monohydrochloride
Guanfacine [INN:BAN]
Guanfacinum
 
Guanfacinum [INN-Latin]
Intuniv
L000286
L013430
LS-174236
Lon798
Lopac-G-1043
Lopac0_000519
MolPort-003-941-447
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide
NCGC00015469-01
NCGC00015469-02
NCGC00015469-06
NCGC00024950-01
NCGC00024950-02
NCGC00024950-03
Prestwick0_000339
Prestwick1_000339
Prestwick2_000339
Prestwick3_000339
SPBio_002298
SPD 503
Tocris-1030
UNII-30OMY4G3MK
ZINC03872738
10
SulpirideapprovedPhase 4, Phase 3, Phase 2, Phase 14415676-16-15355
Synonyms:
( inverted question mark)-Sulpiride
(+-)-Sulpiride
(+/-)-Sulpiride
(?)-Sulpiride
(RS)-(+/-)-sulpiride
15676-16-1
23672-07-3
5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
5-22-08-00105 (Beilstein Handbook Reference)
AC-12181
AC1L1K62
AKOS004912732
Abilit
Aiglonyl
Alimoral
Allphar Brand of Sulpiride
Almirall Brand of Sulpiride
Areu Brand of Sulpiride
Arminol
BPBio1_000233
BPBio1_000463
BPBio1_001255
BRD-A55272860-001-03-9
BRD-A55272860-001-04-7
BRN 0494008
BSPBio_000211
Bio-0717
Biomol-NT_000037
Biomol-NT_000162
C15H23N3O4S
CCRIS 4248
CHEMBL26
CID5355
Calmoflorine
Centrum Brand of Sulpiride
Championyl
Coolspan
D01226
D013469
DB00391
Darleton
Deponerton
Desisulpid
Desitin Brand of Sulpiride
Desmenat
Digton
DivK1c_000278
Dobren
Dogmatil
Dogmatyl
Dogmatyl (TN)
Dolmatil
Dolorgiet Brand of Sulpiride
Dresent
EINECS 239-753-7
EU-0001755
EU-0101050
Eglonil
Eglonyl
Ekilid
Enimon
Equilid
Erempharma Brand of Sulpiride
Eusulpid
Fardalan
Fidelan
Fumouzer Brand of Sulpiride
Guastil
HMS1568K13
HMS500N20
Hennig Brand of Sulpiride
Hexal Brand of Sulpiride
Hoechst Brand of Sulpiride
Hormosan Brand of Sulpiride
I06-0054
IDI1_000278
Isnamide
KBio1_000278
Krewel Brand of Sulpiride
Kylistro
L000579
LS-20058
LS-20059
Lebopride
Levobren
Levopraid
Levosulpirida
Levosulpirida [INN-Spanish]
 
Levosulpiride
Levosulpiride [INN]
Levosulpiridum
Levosulpiridum [INN-Latin]
Lisopiride
Lopac0_001050
MLS000069434
MLS001306443
Magnetic resonance imaging sulpiride
Mariastel
Meresa
Miradol
Mirbanil
Misulvan
MolPort-002-070-475
N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
NCGC00015966-04
NCGC00015966-08
NCGC00024852-02
NCGC00024852-03
NCGC00024852-04
NCGC00024852-05
NINDS_000278
Neogama
Norestran
Normum
Nufarol
Omiryl
Omperan
Oprea1_602476
Ozoderpin
Pharmacia Brand of Sulpiride
Pontiride
Prestwick0_000056
Prestwick1_000056
Prestwick2_000056
Prestwick3_000056
Prestwick_431
Psicocen
Psicofarma Brand of Sulpiride
Pyrikappl
Pyrkappl
R. D. 1403
R.D. 1403
RD 1403
RV-12309
Restful
Rosemont Brand of Sulpiride
S 8010
S-(-)-Sulpiride
S8010_SIGMA
SMR000038923
SPBio_002132
STK368596
Sanofi Synthelabo Brand of Sulpiride
Sanofi-Synthelabo Brand of Sulpiride
Sernevin
Splotin
Spyfarma Brand of Sulpiride
Stamonevrol
Sulp
Sulperide
Sulpirid
Sulpirida
Sulpirida [INN-Spanish]
Sulpiride (JP15/USAN/INN)
Sulpiride [USAN:INN:BAN:JAN]
Sulpiridum
Sulpiridum [INN-Latin]
Sulpitil
Sulpivert
Sulpor
Sulpride
Sulpyrid
Suprium
Sursumid
Synedil
Tepavil
Uriach Brand of Sulpiride
Valirem
Vertigo Meresa
Vertigo-Meresa
Zemorcon
nchembio873-comp17
sulpiride
vertigo neogama
vertigo-neogama
11
Reboxetineapproved, investigationalPhase 4, Phase 3, Phase 12698769-81-4, 71620-89-8123628, 65856
Synonyms:
(+-)-(2R*)-2-((alphaR*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine
(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
(2R)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
(2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
(S,S)-( )-Reboxetine
(S,S)-reboxetine
2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine
71620-89-8
71621-36-8
98769-81-4
98769-83-6
98819-76-2
AC-1247
AC1L2442
AC1L2RJ0
AC1MIDJY
AC1NSKK9
BRD-A43974499-066-01-1
CHEBI:114263
CHEMBL14370
CHEMBL593475
CID10245062
CID10403303
CID10455311
CID127151
 
CID3022645
CID5311403
CID65856
D08472
D09340
DB00234
Davedax
Edronax
Edronax (TN)
Esreboxetine
Esreboxetine (USAN/INN)
LS-178388
LS-93003
MolPort-003-850-135
MolPort-005-942-846
MolPort-005-943-618
NCGC00025335-01
Norebox
Prolift
Reboxetine
Reboxetine (INN)
Reboxetine [INN]
Reboxetine mesylate
Reboxitine
Solvex
Tocris-1982
UNII-947S0YZ36I
Vestra
12
CitalopramapprovedPhase 4, Phase 3, Phase 2, Phase 151259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
13MoxonidineapprovedPhase 41375438-57-24810
14
NicotineapprovedPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 1110354-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-(−)-nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(−)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-(N-methylpyrollidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L(−)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
15
HaloperidolapprovedPhase 4, Phase 3, Phase 2, Phase 114752-86-83559
Synonyms:
1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine
4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
5-21-02-00377 (Beilstein Handbook Reference)
52-86-8
AB00052008
AC-19691
AC1L1G7K
AC1Q77Z0
AKOS000280660
ALDO
Aldo
Aloperidin
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
BIDD:GT0128
BPBio1_000144
BPBio1_001231
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRN 0331267
BSPBio_000130
BSPBio_002096
Bio-0705
Biomol-NT_000035
Bioperidolo
Brotopon
C01814
C21H23ClFNO2
CAS-52-86-8
CCRIS 1630
CHEBI:5613
CHEMBL54
CID3559
D00136
D006220
DB00502
DivK1c_000654
Dozic
Dozix
EINECS 200-155-6
EU-0100583
Einalon S
Eukystol
Fortunan
Galoperidol
H 1512
H0912
H1512_SIGMA
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
HMS502A16
HSDB 3093
Haldol
Haldol Decanoate
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidol [USAN:INN:BAN:JAN]
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
I14-13404
I14-14165
IDI1_000654
 
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
Keselan
L000288
LS-48311
Lealgin Compositum
Lealgin compositum
Linton
Lopac-H-1512
Lopac0_000583
MLS000028450
MLS001146904
McN-JR-1625
Mixidol
MolPort-000-883-311
NCGC00015500-01
NCGC00015500-02
NCGC00015500-06
NCGC00015500-14
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NINDS_000654
NSC 170973
NSC 615296
NSC170973
NSC615296
Novo-Peridol
Oprea1_509923
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Prestwick_250
Probes1_000255
Probes2_000296
QTL1_000042
R 1625
R-1625
S1920_Selleck
SMR000058303
SPBio_001236
SPBio_002069
SPECTRUM1500325
Serenace
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
Spectrum_000861
Tocris-0931
UNII-J6292F8L3D
Ulcolind
Uliolind
Vesalium
WLN: T6NTJ A3VR DF& DQ DR DG
cMAP_000037
gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
haloperidol
16
Vareniclineapproved, investigationalPhase 4, Phase 3, Phase 2273249296-44-45310966
Synonyms:
249296-44-4
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine
7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline
AC1L55H0
AC1Q4W6H
AKOS005145561
AR-1H2911
CHEBI:430452
CHEMBL1396
CID170361
CP 526555
 
CP-526,555
Champix
Chantix
D08669
HSDB 7591
I14-1963
LS-187375
UNII-W6HS99O8ZO
Varenicline
Varenicline (INN)
Varenicline tartrate
varenicline
17
Testosteroneapproved, investigationalPhase 456358-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
18
MentholapprovedPhase 426062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
19
Oxytocinapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 143950-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
20
FamotidineapprovedPhase 4, Phase 2, Phase 36176824-35-63325
Synonyms:
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide
(1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide
(1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide
3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine
3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide
3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro
3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide
76824-35-6
AC-11713
AC1NWASH
AC1Q50E0
AC1Q50E1
Amfamox
Antodine
Apo-Famotidine
Apogastine
BIDD:GT0759
BPBio1_000098
BSPBio_000088
Bestidine
Bio-0739
Blocacid
Brolin
C8H15N7O2S3
CAS-76824-35-6
CHEBI:4975
CHEMBL902
CID5702160
CPD000058961
Cepal
Confobos
Cronol
Cuantin
DB00927
Dibrit 40
Digervin
Dinul
Dipsin
Dispromil
Dispronil
Duovel
Durater
EU-0100497
Evatin
F 6889
F0530
F6889_SIGMA
FAMOTIDINE PRESERVATIVE FREE
FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
Fadin
Fadine
Fadyn
Fagastine
Famo
Famocid
Famodar
Famodil
Famodin
Famodine
Famogard
Famonit
Famopsin
Famos
Famosan
Famotal
Famotep
Famotidina
Famotidina [Spanish]
Famotidine
Famotidine [USAN:BAN:INN:JAN]
Famotidinum
Famotidinum [Latin]
Famotin
Famovane
Famowal
Famox
Famoxal
Famtac
Famulcer
Fanobel
Fanosin
Fanox
Farmotex
Ferotine
Fibonel
Fluxid
Fudone
Ganor
Gaster
Gastridan
Gastridin
Gastrion
Gastro
Gastrodomina
Gastrofam
Gastropen
Gastrosidin
H2 Bloc
HMS1568E10
HMS2051A07
HMS2089I12
HS-0054
HSDB 3572
 
Hacip
Huberdina
InChI=1/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
Ingastri
Invigan
L 643341
L003830
L013386
LS-121117
Lecedil
Logos
Lopac-F-6889
Lopac0_000497
MK 208
MK-208
MLS000028583
MLS000758205
MLS001423994
Mensoma
Midefam
MolPort-002-557-620
MolPort-003-941-395
Mosul
Motiax
Muclox
Mylanta AR
N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine
N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
NCGC00015446-01
NCGC00015446-02
NCGC00015446-03
NCGC00015446-06
NCGC00018276-01
NCGC00018276-02
NCGC00093899-01
NCGC00093899-02
NCGC00093899-03
Neocidine
Nevofam
Notidin
Novo-Famotidine
Nu-Famotidine
Nulceran
Nulcerin
PDSP1_000398
PDSP2_000396
PEPCID
PEPCID COMPLETE
PEPCID PRESERVATIVE FREE
PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
Panalba
Pepcid
Pepcid AC
Pepcid AC Gelcaps
Pepcid RPD
Pepcidac
Pepcidin
Pepcidin Pepcidine
Pepcidin Rapitab
Pepcidina
Pepcidine
Pepdif
Pepdine
Pepdul
Pepfamin
Peptan
Peptidin
Peptifam
Pepzan
Prestwick2_000104
Prestwick3_000104
Prestwick_212
Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl)
Purifam
Quamatel
Quamtel
Renapepsa
Restadin
Rogasti
Rubacina
SAM001247033
SMR000058961
STK527689
Sedanium-R
Sigafam
Supertidine
TL8005267
Tairal
Tamin
Tipodex
Topcid
Ulcatif
Ulceprax
Ulcofam
Ulfagel
Ulfam
Ulfamid
Ulfinol
Ulgarine
Vagostal
Weimok
Whitidin
YM 11170
YM-11170
YM-1170
Yamarin
famotidine
21
Valproic Acidapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 132799-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propyl-pentanoic acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VPA
Valcote
Valparin
Valproate
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
acide valproïque
acidum valproicum
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
ácido valproico
22
SimvastatinapprovedPhase 4, Phase 3, Phase 2, Phase 151979902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
23
Fluvoxamineapproved, investigationalPhase 4, Phase 34854739-18-33404, 5324346
Synonyms:
(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime
2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine
54739-18-3
61718-82-9 (maleate)
AB00514702
AC-1679
AC1NT50J
AC1Q4JNU
AR-1D5360
BIDD:GT0609
BPBio1_001199
BRD-K53517854-050-03-2
BSPBio_001089
C07571
C15H21F3N2O2
CHEBI:5138
CHEMBL814
CID5324346
D07984
DB00176
Dumirox
Dumyrox
Faverin
 
Fevarin
Floxyfral
Fluvoxamina
Fluvoxamina [INN-Spanish]
Fluvoxamine
Fluvoxamine (INN)
Fluvoxamine [INN:BAN]
Fluvoxamine maleate
Fluvoxamine-CR
Fluvoxaminum
Fluvoxaminum [INN-Latin]
I01-8382
LS-101999
Lopac0_000495
Luvox
Maveral
MolPort-005-943-374
NCGC00018193-07
NCGC00021870-04
NCGC00021870-05
Prestwick2_000995
Prestwick3_000995
UNII-O4L1XPO44W
fluvoxamine
fluvoxamine-CR
24
PerphenazineapprovedPhase 4, Phase 3, Phase 29358-39-94748
Synonyms:
.gamma.-[4-(.beta.-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]
1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine
1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride
2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine
2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine
2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine
2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine
2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol
2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol
4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol
58-39-9
AB00052390
AC-12196
AC1L1IVB
AI3-50151
AKOS000664046
Apo-Perphenazine
BAS 00139131
BIDD:GT0150
BPBio1_000188
BRD-K10995081-001-05-5
BSPBio_000170
BSPBio_002376
C07427
C21H26ClN3OS
CAS-58-39-9
CHEBI:8028
CHEMBL567
CID4748
CPD000058180
Chlorperphenazine
Chlorpiprazine
D00503
D010546
DB00850
Decentan
DivK1c_000880
EINECS 200-381-5
EU-0072164
EU-0100930
Emesinal
Etaperazin
Etaperazine
Ethaperazine
Etrafon-A
Etrafon-Forte
F-Mon
F-mon
Fentazin
HMS1568I12
HMS1922M14
HMS2093M15
HMS502L22
HSDB 3379
I06-1508
IDI1_000880
KBio1_000880
KBio2_002090
KBio2_004658
 
KBio2_007226
KBio3_001596
KBioGR_001445
KBioSS_002090
L000919
LS-112185
Lopac-P-6402
Lopac0_000930
MLS000069637
MLS001146929
MolPort-001-727-942
NCGC00015826-01
NCGC00015826-02
NCGC00015826-03
NCGC00015826-06
NCGC00015826-10
NCGC00024092-03
NCGC00024092-04
NCGC00024092-05
NCGC00024092-06
NINDS_000880
NSC 150866
NSC150866
Oprea1_603835
P 6402
P6402_SIGMA
PZC
Perfenazina
Perfenazina [INN-Spanish]
Perfenazina [Italian]
Perfenazine
Perphenan
Perphenazin
Perphenazine (JP15/USP/INN)
Perphenazine [INN:BAN:JAN]
Perphenazine [Trilafon]
Perphenazine maleate
Perphenazinum
Perphenazinum [INN-Latin]
Perphénazine
Prestwick0_000125
Prestwick1_000125
Prestwick2_000125
Prestwick3_000125
Prestwick_536
SAM002264637
SCH-3940
SMR000058180
SPBio_001603
SPBio_002109
SPECTRUM1503934
SR-01000000137-4
STK019818
STOCK1S-21551
Sch 3940
Spectrum2_001602
Spectrum3_000758
Spectrum4_000843
Spectrum5_001493
Spectrum_001610
Thilatazin
Tranquisan
Trifaron
Trilafon
Trilifan
Triphenot
UNII-FTA7XXY4EZ
WLN: T C666 BN ISJ EG B3- AT6N DNTJ D2Q
gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine
nchembio873-comp26
perphenazine
25
Memantineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 118119982-08-24054
Synonyms:
1,3-Dimethyl-5-adamantanamine
1-Amino-3,5-dimethyladamantane
19982-08-2
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyladamantan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
BBL000737
BPBio1_001117
BPBio1_001270
BSPBio_001015
Biomol-NT_000209
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DMAA
DivK1c_000068
EU-0053634
Ebixa
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
 
KBio2_006223
KBio3_001926
KBioGR_001543
KBioSS_001087
LS-157051
Lopac0_000861
Memantin
Memantina
Memantina [INN-Spanish]
Memantine
Memantine (INN)
Memantine HCL
Memantine Hydrochloride
Memantine [INN:BAN]
Memantine [INN]
Memantinum
Memantinum [INN-Latin]
MolPort-002-041-858
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Namenda
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
ST057652
STK520682
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
Spectrum_000607
UNII-W8O17SJF3T
ZERO/006024
memantine
26
GalantamineapprovedPhase 4, Phase 2, Phase 3106357-70-09651, 908828, 9651
Synonyms:
(-)-Galanthamine
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol
1551-02-6
1953-04-4
1dx6
1qti
357-70-0
4-27-00-02184 (Beilstein Handbook Reference)
736-79-8
AC-20240
AC1L1TIM
BIDD:GT0517
BPBio1_000480
BRD-K49481516-004-03-5
BRD-K49481516-004-04-3
BRN 0093736
BSPBio_000436
BSPBio_003416
C08526
CHEBI:42944
CHEMBL659
CID9651
D04292
DivK1c_000590
GNT
Galantamin
Galantamina
Galantamina [INN-Spanish]
Galantamine
Galantamine (USAN/INN)
Galantamine [USAN:INN]
Galantaminum
Galantaminum [INN-Latin]
Galanthamine
Galanthamine hydrobromide
Galanthaminum
 
HMS2089H03
HSDB 7361
IDI1_000590
InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
Jilkon
KBio1_000590
KBio2_001751
KBio2_004319
KBio2_006887
KBio3_002636
KBioGR_001417
KBioSS_001751
LS-71039
Lycoremin
Lycoremine
MolPort-002-521-885
NCGC00024731-02
NINDS_000590
NSC 100058
Prestwick0_000588
Prestwick1_000588
Prestwick2_000588
Prestwick3_000588
Probes1_000055
Probes2_000395
Razadyne ER
Reminyl
Reminyl (TN)
SDCCGMLS-0066737.P001
SMP1_000131
SPBio_002655
STOCK1N-46108
Spectrum3_001738
Spectrum4_000839
Spectrum5_001673
Spectrum_001271
UNII-0D3Q044KCA
galanthamine
27
Histamineapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1105075614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-(4-imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
4-imidazoleethylamine
5-Imidazoleethylamine
5-imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminoethylglyoxaline
beta-aminoethylimidazole
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
28
EthanolapprovedPhase 4, Phase 3, Phase 2, Phase 1213764-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
29
TrifluoperazineapprovedPhase 4, Phase 35117-89-55566
Synonyms:
10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine
10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine
10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine
10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride
117-89-5
2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
AB00053558
AC1L1KMT
AC1Q3ZYE
AKOS001487920
Apo-Trifluoperazine
Apo-trifluoperazine (TN)
BIDD:PXR0132
BPBio1_000338
BPBio1_001345
BRD-K89732114-001-02-6
BRD-K89732114-001-03-4
BRD-K89732114-300-05-5
BSPBio_000306
BSPBio_001190
BSPBio_002928
Bio1_000458
Bio1_000947
Bio1_001436
Bio2_000435
Bio2_000915
Biomol-NT_000060
C07168
C21H24F3N3S
CAS-440-17-5
CCRIS 6994
CHEBI:101325
CHEBI:45951
CHEMBL422
CID5566
Calmazine
D08636
DB00831
DB08616
DivK1c_000843
EINECS 204-219-4
Eskazine
Eskazinyl
Fluoperazine
Flurazine
HMS1362L11
HMS1792L11
HMS1990L11
HMS2089J11
HSDB 3195
IDI1_000843
IDI1_002190
Jatroneural
KBio1_000843
KBio2_000530
KBio2_001148
KBio2_002431
KBio2_003098
KBio2_003716
KBio2_004999
KBio2_005666
KBio2_006284
KBio2_007567
KBio3_000959
KBio3_000960
KBio3_002148
KBio3_002910
KBioGR_000530
KBioGR_000835
KBioGR_002431
KBioSS_000530
KBioSS_001148
KBioSS_002437
L001075
LS-105595
Lopac-T-8516
Lopac0_001232
MLS002702821
Modalina
MolPort-001-727-956
 
NCGC00013226
NCGC00013226-02
NCGC00013226-03
NCGC00013226-04
NCGC00013226-12
NCGC00024251-03
NCGC00024251-04
NCGC00024251-05
NCGC00024251-06
NCGC00024251-07
NCI17474
NCI60_001427
NCI60_004087
NCIStruc1_001127
NCIStruc2_001093
NINDS_000843
NSC 17474
NSC 46061
NSC-17474
NSC17474
NSC46061
Novo-Trifluzine
PDSP1_001300
PDSP2_001284
PMS Trifluoperazine
Prestwick0_000313
Prestwick1_000313
Prestwick2_000313
Prestwick3_000313
QTL1_000085
RP 7623
SKF 5019
SMR001566649
SPBio_000755
SPBio_002525
SR-01000003020-6
STK182873
STOCK1S-51401
Spectrum2_000828
Spectrum3_001374
Spectrum4_000368
Spectrum5_001553
Spectrum_000668
Stelazine
Stelazine (*Dihydrochloride*)
Stelazine Concentrate
Stellazine
Synklor
TFP
Terfluzine
Trazine
Trifluoperazin
Trifluoperazina
Trifluoperazina [INN-Spanish]
Trifluoperazina [Italian]
Trifluoperazine
Trifluoperazine (INN)
Trifluoperazine Dihydrochloride
Trifluoperazine HCl
Trifluoperazine Hydrochloride
Trifluoperazine [INN:BAN]
Trifluoperazine dihydrochloride
Trifluoperazinum
Trifluoperazinum [INN-Latin]
Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
Trifluoromethylperazine
Trifluoroperazine
Trifluoroperazine Dihydrochloride
Trifluoroperazine Hydrochloride
Trifluoroperazine dihydrochloride
Trifluperazine
Triflurin
Trifluroperizine
Triftazin
Triftazine
Triperazine
Tripfluoperazine Hydrochloride
Triphtazin
Triphtazine
Triphthasine
Triphthazine
Triphthazine Dihydrochloride
Tryptazine
Tryptazine Dihydrochloride
UNII-214IZI85K3
cMAP_000048
nchembio873-comp70
trifluoperazine
30
Lamotrigineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 118584057-84-13878
Synonyms:
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
84057-84-1
AC-10298
AC1L1GWT
BIDD:GT0794
BW 430C
BW-430C
Bio-0056
C047781
CHEBI:138727
CHEBI:6367
CHEMBL741
CID3878
CPD000058464
Crisomet
D00354
DB00555
Desitin Brand of Lamotrigine
EINECS 281-901-8
EU-0100688
EUR-1048
Faes Brand of Lamotrigine
GI 267119X
GW 273293
Glaxo Wellcome Brand of Lamotrigine
GlaxoSmithKline Brand of Lamotrigine
HMS2051C10
HMS2089M08
HMS2093P21
HSDB 7526
Juste Brand of Lamotrigine
L 3791
L3791_SIGMA
LS-155249
 
Labileno
Lamictal
Lamictal (TN)
Lamictal CD
Lamictal Cd
Lamictal ODT
Lamictal XR
Lamictin
Lamiktal
Lamitor
Lamotrigina
Lamotrigina [Spanish]
Lamotrigine
Lamotrigine (JAN/USAN/INN)
Lamotrigine [USAN:INN:BAN]
Lamotriginum
Lamotriginum [Latin]
Lopac-L-3791
Lopac0_000688
MLS000069685
MLS000759486
MLS001077325
MolPort-003-666-744
NCGC00015605-01
NCGC00015605-02
NCGC00015605-06
NCGC00015605-08
NCGC00022936-02
NCGC00022936-04
NCGC00022936-05
NSC746307
SAM001246697
SMP2_000303
SMR000058464
STK628377
Tocris-1611
UNII-U3H27498KS
ZINC00013156
lamotrigine
31
LorazepamapprovedPhase 4, Phase 3, Phase 2, Phase 1124846-49-13958
Synonyms:
(+-)-7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
(+/-)-Lorazepam
(±)-Lorazepam
5-25-02-00248 (Beilstein Handbook Reference)
7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-1,4-benzodiazepin-2(3H)-one
7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
846-49-1
AC1L1H3H
AHP Brand of Lorazepam
Almazine
Alzapam
Anxiedin
Anxira
Anzepam
Aplacasse
Aplacassee
Apo Lorazepam
Apo-Lorazepam
ApoLorazepam
Apotex Brand of Lorazepam
Aripax
Ativan
Ativan (TN)
Azurogen
BRN 0759084
Baxter Brand of Lorazepam
Bonatranquan
Bonton
CHEBI:116959
CHEMBL580
CID3958
CPD000058410
D00365
D008140
DB00186
DEA No. 2885
Delormetazepam
Demethyllormetazepam
Desitin Brand of Lorazepam
DivK1c_000965
Dolorgiet Brand of Lorazepam
Donix
Duralozam
Durazolam
EINECS 212-687-6
Efasedan
Emotion
Emotival
Equitam
HMS2052H07
HMS503A11
IDI1_000965
Idalprem
KBio1_000965
Kalmalin
L-Lorazepam Acetate
L1764_SIGMA
LS-34141
Larpose
Laubeel
Llorens Brand of Lorazepam
Lomesta
Lopam
Lorabenz
Lorafen
Loram
Lorans
Lorapam
Lorat
Lorax
Loraz
Lorazene
Lorazep
Lorazepam (JP15/USP/INN)
Lorazepam AHP Brand
Lorazepam Apotex Brand
Lorazepam Baxter Brand
Lorazepam Desitin Brand
Lorazepam Dolorgiet Brand
Lorazepam Fabra
Lorazepam Genericon
Lorazepam Intensol
Lorazepam Lannacher
Lorazepam Llorens Brand
Lorazepam Medical
Lorazepam Medical Brand
Lorazepam Medix Brand
Lorazepam Novartis Brand
Lorazepam Novopharm Brand
Lorazepam Nu-Pharm Brand
Lorazepam Riemser Brand
Lorazepam Wyeth Brand
Lorazepam [USAN:INN:BAN:JAN]
Lorazepam ct-Arzneimittel Brand
 
Lorazepam neuraxpharm
Lorazepam neuraxpharm Brand
Lorazepam preservative free
Lorazepam ratiopharm
Lorazepam ratiopharm Brand
Lorazepam-Efeka
Lorazepam-neuraxpharm
Lorazepam-ratiopharm
Lorazepamum
Lorazepamum [INN-Latin]
Lorazepan Chobet
Lorazepan Richet
Lorazin
Lorazon
Lorenin
Loridem
Lorivan
Lormetazepam
Lorsedal
Lorsilan
Lorzem
Lozepam
Max Pax
Medical Brand of Lorazepam
Medical, Lorazepam
Medix Brand of Lorazepam
Merck dura Brand of Lorazepam
Merlit
Methyllorazepam
MolPort-002-051-769
N-Methyllorazepam
NCGC00159439-02
NINDS_000965
NSC 289758
NSC289758
Nervistop L
Nervistopl
Norlormetazepam
Novartis Brand of Lorazepam
Novhepar
Novo Lorazem
Novo-Lorazem
Novolorazem
Novopharm Brand of Lorazepam
Nu Loraz
Nu Pharm Brand of Lorazepam
Nu-Loraz
Nu-Pharm Brand of Lorazepam
NuLoraz
O-Chlorooxazepam
O-Chloroxazepam
Orfidal
Orfidal Wyeth
Pro Dorm
Pro dorm
Psicopax
Punktyl
Quait
Renaquil
Riemser Brand of Lorazepam
Rocosgen
SAM001246833
Securit
Sedatival
Sedazin
Sedicepan
Sedizepan
Serra Pamies Brand of Lorazepam
Sidenar
Silence
Sinestron
Somagerol
Stapam
Tavor
Temesta
Tolid
Tranqipam
Trapax
UNII-O26FZP769L
Upan
Vigiten
WLN: T67 GMV JN IHJ CG IQ KR BG
WY4036
Wy 4036
Wy-4036
Wyeth Brand of Lorazepam
Wyeth, Orfidal
Wypax
ct Arzneimittel Brand of Lorazepam
ct-Arzneimittel Brand of Lorazepam
lorazep von ct
lorazepam
lorazepam (Ativan)
nchembio747-comp26
neuraxpharm Brand of Lorazepam
o-Chlorooxazepam
o-Chloroxazepam
ratiopharm Brand of Lorazepam
32
PimozideapprovedPhase 4, Phase 3, Phase 2112062-78-416362
Synonyms:
1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H- benzimidazol-2-one
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
2062-78-4
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
5-24-02-00367 (Beilstein Handbook Reference)
AB00052215
AC1L27SR
AC1Q4M09
AC1Q4NM9
ASTA Medica Brand of Pimozide
Antalon
BCBcMAP01_000043
BIDD:GT0435
BPBio1_000304
BRD-K01292756-001-06-0
BRN 0729089
BSPBio_000276
BSPBio_001439
BSPBio_002941
C07566
C28H29F2N3O
CAS-2062-78-4
CCRIS 9172
CHEBI:8212
CHEMBL1423
CID16362
D00560
D010868
DB01100
DivK1c_000386
EINECS 218-171-7
EU-0100946
HMS1568N18
HMS1791H21
HMS1921H19
HMS1989H21
HMS2089C11
HMS2092F09
HMS501D08
Halomonth
IDI1_000386
Janssen Brand of Pimozide
KBio1_000386
KBio2_000925
KBio2_003493
KBio2_006061
KBio3_002441
KBioGR_000720
KBioSS_000925
L000494
LS-33236
Lopac-P-1793
Lopac0_000946
MLS000028410
 
MLS001077311
MLS002702058
McN-JR 6238
McN-JR-6238
MolPort-001-736-597
NCGC00015802-01
NCGC00015802-02
NCGC00015802-04
NCGC00015802-15
NCGC00016601-01
NCGC00022282-03
NCGC00024888-01
NCGC00024888-02
NCGC00024888-03
NCGC00024888-04
NCGC00024888-05
NCGC00024888-06
NCGC00024888-07
NCIMech_000356
NINDS_000386
NSC 170984
NSC170984
Neoperidole
Opiran
Orap
Orap (TN)
Orap forte
P 1793
P1793_SIGMA
Pharmascience Brand of Pimozide
Pimozida
Pimozida [INN-Spanish]
Pimozide
Pimozide (JAN/USP/INN)
Pimozide [USAN:INN:BAN:JAN]
Pimozidum
Pimozidum [INN-Latin]
Prestwick0_000308
Prestwick1_000308
Prestwick2_000308
Prestwick3_000308
Prestwick_395
Primozida
Primozida [INN-Spanish]
R 6238
R-6238
R6238
SMP1_000241
SMR000058385
SPBio_001211
SPBio_002495
SPECTRUM1501134
Spectrum2_001026
Spectrum3_001451
Spectrum4_000420
Spectrum5_001308
Spectrum_000445
Tocris-0937
UNII-1HIZ4DL86F
WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF
pimozida
pimozide
33
AcetylcholineapprovedPhase 4, Phase 3, Phase 280551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
34
Methylphenidateapproved, investigationalPhase 4, Phase 3, Phase 2375113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
 
Methyl phenidyl acetate
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
35
Cocaineapproved, illicitPhase 4, Phase 2, Phase 151150-36-25760, 446220
Synonyms:
(-)-Cocaine
(-)-Cocaine base
(1R,2R,3S,5S)-2-(methoxycarbonyl)tropan-3-yl benzoate
(1R,2R,3S,5S)-2-Methoxycarbonyltropan-3-yl benzoate
(R)-Cocaine
(−)-cocaine
1-Cocaine
1i7z
1q72
2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)
2-beta-Carbomethoxy-3-beta-benzoxytropane
2-beta-Tropanecarboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester)
2beta-Carbomethoxy-3beta-benzoxytropane
3-Tropanylbenzoate-2-carboxylic acid methyl ester
3beta-Hydroxy-2beta-tropanecarboxylic acid methyl ester benzoate (ester)
50-36-2
53-21-4 (hydrochloride)
610089_ALDRICH
610089_FLUKA
AC-16037
AC-20208
AC1L1EK2
AC1L1L2T
AC1L3U2D
AC1L9JBL
Allococaine
Allopseudococaine
Badrock
Bazooka
Benzoylethylecgonine
Benzoylmethylecgonine
Bernice
Bernice [Street Name]
Bernies
Beta-Cocain
Blast
Blizzard
Blow
Blow [Street Name]
Bouncing Powder
Bump
Burese
C" Carrie
C01416
C8912_SIGMA
CHEBI:27958
CID11779748
CID2826
CID446220
CID5760
COC
CPD-9776
Cabello
Candy
Carrie
Caviar
Cecil
Cecil [Street Name]
Charlie
Chicken Scratch
Cholly
Coca
Cocain
Cocaina
Cocaine
Cocaine (TN)
Cocaine (USP)
Cocaine Free Base
Cocaine [BAN]
Cocaine free base
Cocaine solution
Cocaine-M
Cocainum
Cocktail
Coke
Cola
Corine
Crack
Crack cocaine
D-pseudococaine
D00110
DB00907
DEA No. 9041
Dama Blanca
Dama blanca
Delcaine
Depsococaine
Dextrocaine
DivK1c_000975
Dust
EINECS 200-032-7
Ecgonine methyl ester benzoate
Ecgonine methyl ester benzoate solution
Ecgonine, methyl ester, benzoate (ester)
 
Eritroxilina
Erytroxylin
Flake
Flake [Street Name]
Flex
Florida Snow
Foo Foo
Freeze
G-Rock
Girl
Girl [Street Name]
Gold Dust
Gold dust
Gold dust [Street Name]
Goofball
Green Gold
Green gold
HSDB 6469
Happy Dust
Happy Powder
Happy Trails
Happy dust
Happy dust [Street Name]
Happy powder
Happy trails
Heaven
Hell
IDI1_000975
Isocaine
Isococain
Isococaine
Jam
KBio1_000975
Kibbles N' Bits
Kibbles n' Bits
Kokain
Kokan
Kokayeen
L-Cocain
L-Cocaine
L000836
LS-157759
Lady
Lady [Street Name]
Leaf
MLS002320697
Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl 3beta-hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylate benzoate (ester)
Methyl Benzoylecgonine
Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl benzoylecgonine
MolPort-002-535-520
MolPort-003-937-722
Moonrocks
NCGC00159467-02
NINDS_000975
Neurocaine
Nose candy
Pimp's Drug
Pimp's drug
Prime Time
Pseudoallococaine
Pseudococaine
Rock
Rock [Street Name]
SMR001338843
STOCK1N-68258
Sleighride
Snort
Snow
Snow (birds)
Star Dust
Star dust
Star-Spangled Powder
Star-spangled powder
Sugar
Sweet Stuff
Toke
Toot
Toot [Street Name]
Trails
UNII-I5Y540LHVR
White girl or lady
Yeyo
Zip
[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester
beta-Cocain
cocaine
cocainum
d-Pseudococaine
l-Cocain
methyl (1S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
methyl (3S,4R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
nchembio.284-comp4
36
DopamineapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
37
AmantadineapprovedPhase 4, Phase 3, Phase 2, Phase 167768-94-52130
Synonyms:
1-Adamantamine
1-Adamantanamine
1-Adamantanamine (8CI)
1-Adamantylamine
1-Aminoadamantane
1-Aminotricyclo(3.3.1.1(sup 3,7))decane
1-adamantanamine
1-adamantylamine
1-aminoadamantane
138576_ALDRICH
665-66-7 (hydrochloride)
768-94-5
AB00514655
AC-11992
AC1L1CZI
AC1Q4UAF
AC1Q5396
ADAMANTANE,1-AMINO
AKOS000113994
AKOS000119324
Adamantamine
Adamantanamine
Adamantylamine
Amant
Amantadina
Amantadina [INN-Spanish]
Amantadine
Amantadine (INN)
Amantadine Base
Amantadine HCL
Amantadine Hydrochloride
Amantadine [INN:BAN]
Amantadinum
Amantadinum [INN-Latin]
Amantidine
Ambap768-94-5
Aminoadamantane
BIA4304
BIDD:GT0757
BPBio1_000368
BRN 2204333
BSPBio_000334
BSPBio_001570
BSPBio_001822
Bio-0821
C06818
C10H17N
CHEBI:2618
CHEMBL660
CID2130
D07441
DB00915
DivK1c_000815
EINECS 212-201-2
Endantadine
Gen-Amantadine
HMS1791O12
HMS1989O12
HSDB 3202
I14-1101
IDI1_000815
InChI=1/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H
KBio1_000815
KBio2_000390
 
KBio2_002958
KBio2_005526
KBio3_001322
KBioGR_000548
KBioSS_000390
L000868
LS-157049
Lopac-A-1260
Lopac0_000004
Mantadine
MolPort-001-661-700
MolPort-001-760-587
MolPort-001-791-102
NCGC00015036-01
NCGC00015036-07
NCGC00162039-01
NCGC00162039-02
NCGC00162039-03
NCGC00162039-04
NCGC00179597-01
NCIOpen2_001059
NINDS_000815
NSC 341865
NSC341865
NSC83653
OR14310
Oprea1_248648
Pk-Merz
Pk-merz
Prestwick0_000407
Prestwick1_000407
Prestwick2_000407
Prestwick3_000407
SPBio_000002
SPBio_002273
STK298781
Spectrum2_000081
Spectrum3_000291
Spectrum4_000134
Spectrum5_000772
Spectrum_000030
Symadine
Symmetrel
TCMDC-125869
TL8005280
Tricyclo(3.3.1.1(3,7))-decan-1-amine
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine
Tricyclo(3.3.1.1(sup 3.7))decan-1-amine
Tricyclo(3.3.1.13,7)decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Tricyclo[3.3.1.1(sup3,7)]decan-1-amine
Tricyclo[3.3.1.1^3,7]decan-1-amine
UNII-BF4C9Z1J53
Viregyt
Virosol
WLN: L66 B6 A B- C 1B ITJ BZ
Wiregyt
adamantan-1-amine
adamantan-1-ylamine
amantadine
amantadine hydrochloride
tricyclo[3.3.1.1(3,7)]decan-1-ylamine
tricyclo[3.3.1.1(3,7)]decane-1-amine
tricyclo[3.3.1.1~3,7~]decan-1-amine
38
Pramipexoleapproved, investigationalPhase 4, Phase 3139104632-26-059868, 119570
Synonyms:
(-)-Pramipexole
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole
(S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
104632-26-0
111GE001
2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
2-amino-6-propylaminotetrahydrobenzothiazole
AC1L3P1T
BIDD:GT0250
C10H17N3S
CHEBI:8356
CHEMBL301265
CID119570
CPD000449298
D05575
DivK1c_006916
Furfuryl Acetate
HMS2051A21
HMS2090C15
KBio1_001860
KBio2_002340
KBio2_004908
 
KBio2_007476
KBioSS_002343
LS-40722
MLS000758250
MLS001423952
Mirapex
MolPort-003-849-957
NCGC00167441-01
Pramipexol
Pramipexol [Spanish]
Pramipexole
Pramipexole (USAN/INN)
Pramipexole 2HCl Monohydrate
Pramipexole [USAN:INN]
Pramipexole hydrochloride
Pramipexolum
Pramipexolum [Latin]
SAM001247006
SBB070477
SMR000449298
SND-919
SUD919CL2Y
SpecPlus_000820
Spectrum5_001453
Spectrum_001838
U-98528E
pramipexole
39
DonepezilapprovedPhase 4, Phase 3, Phase 2286120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
40
MethotrimeprazineapprovedPhase 4, Phase 3, Phase 2860-99-172287
Synonyms:
(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine
2-Methoxytrimeprazine
 
Levomepromazina
Levomepromazine
Levomepromazinum
Methotrimeprazine
41
Olanzapineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1399132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
 
LY-170053
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
42
ZiprasidoneapprovedPhase 4, Phase 3, Phase 2, Phase 1145146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
43
EtomidateapprovedPhase 46533125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
44
ClozapineapprovedPhase 4, Phase 3, Phase 2, Phase 11175786-21-02818
Synonyms:
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
5786-21-0
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
AC-280
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AKOS005064444
AR-1I2412
Asaleptin
BRD-K37289225-001-09-1
BRN 0764984
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
C 6305
C06924
C18H19ClN4
C6305_SIGMA
CAS-5786-21-0
CCRIS 9171
CHEBI:3766
CHEMBL42
CID2818
CLOZARIL
CPD000058365
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapinum
Clozapinum [INN-Latin]
Clozaril
Clozaril (TN)
D00283
D003024
DB00363
DivK1c_000343
EINECS 227-313-7
EU-0100276
FT-0082373
Fazaclo
Fazaclo ODT
HF-1854
HF1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
HMS501B05
 
HSDB 6478
I06-0047
InChI=1/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Iprox
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
KS-1166
L000195
L013417
LEX-123
LS-60881
LX 100-129
Leponex
Lepotex
Lopac-C-6305
MLS000028472
MLS001077282
MolPort-001-728-041
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-07
NCGC00015254-17
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-13
NINDS_000343
Prestwick0_000350
Prestwick1_000350
Prestwick_693
S2459_Selleck
SAM002548976
SMR000058365
SPBio_000798
SPBio_002340
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
Spectrum_000139
Tocris-0444
UNII-J60AR2IKIC
W-801
clozapine
clozapine(tautomer)
45
Propofolapproved, investigational, vet_approvedPhase 410822078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
46
MetforminapprovedPhase 4, Phase 31803657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
47
Risperidoneapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1492106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
48
Aripiprazoleapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1358129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
CPD000466383
 
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
49
Clonazepamapproved, illicitPhase 4, Phase 3321622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
DEA No. 2737
 
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
50
Rosiglitazoneapproved, investigationalPhase 4220122320-73-477999
Synonyms:
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
122320-73-4
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione
5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
AC-3459
AC1L2U9N
Avandia
BRD-A97437073-001-02-3
BRD-A97437073-001-03-1
BRL49653
BSPBio_002693
Brl 49653
Brl-49653
C18H19N3O3S
CID77999
D08491
DB00412
Gaudil
Gaudil (TN)
HMS1922J11
HMS2094O13
HSDB 7555
I06-0141
IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin)
KBio2_002183
KBio2_004751
KBio2_007319
KBio3_001913
 
KBioGR_001609
KBioSS_002183
LS-151340
MolPort-002-508-212
NCGC00095124-01
NCGC00095124-02
NCGC00095124-03
RGZ
RSG
Rosi
Rosigilitazone
Rosigliazone maleate
Rosiglitazon
Rosiglitazona
Rosiglitazone
Rosiglitazone (INN)
Rosiglitazone [INN:BAN]
Rosiglitazone maleate
Rosiglitazonum
Rosiglizole
S00306
SPBio_001142
SPECTRUM1504263
STOCK6S-23924
Spectrum2_001241
Spectrum3_000997
Spectrum4_001125
Spectrum5_001464
Spectrum_001703
TDZ 01
UNII-05V02F2KDG
[3H]rosiglitazone
rosiglitazona
rosiglitazone
rosiglitazone (Avandia)
rosiglitazonum

Interventional clinical trials:

(show top 50)    (show all 2888)
idNameStatusNCT IDPhase
1Tandospirone Combined With Atypical Antipsychotic Drugs in SchizophreniaUnknown statusNCT02040883Phase 4
2Omega-3 Fatty Acids Efficacy in First-episode of SchizophreniaUnknown statusNCT02210962Phase 4
3Magnetic Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaUnknown statusNCT00186771Phase 4
4A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaUnknown statusNCT01490567Phase 4
5The New Strategy for Pharmacological Treatment in People With SchizophreniaUnknown statusNCT00352339Phase 4
6Electroconvulsive Therapy (ECT) in Patients With Super Refractory SchizophreniaUnknown statusNCT02049021Phase 4
7Diabetes Prevention Program in Schizophrenia [DPPS]Unknown statusNCT00182494Phase 4
8Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of SchizophreniaUnknown statusNCT01300364Phase 4
9High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to RisperidoneUnknown statusNCT00539071Phase 4
10Association of Amisulpride Response in Schizophrenia With Brain ImageUnknown statusNCT02095938Phase 4
11Alleviating the Metabolic Side Effects of Antipsychotic MedicationsUnknown statusNCT01567124Phase 4
12Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With SchizophreniaUnknown statusNCT01012830Phase 4
13Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and PredictorsUnknown statusNCT00802919Phase 4
14Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of SchizophreniaUnknown statusNCT00395915Phase 4
15Identification and Treatment of the Liability to Develop SchizophreniaUnknown statusNCT00305474Phase 4
16Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in SchizophreniaUnknown statusNCT00469664Phase 4
17Varenicline Adjunctive Treatment in SchizophreniaUnknown statusNCT00492349Phase 4
18PREvent First Episode Relapse (PREFER)Unknown statusNCT00220714Phase 4
19Antipsychotic Effects on Brain Function in SchizophreniaUnknown statusNCT01913327Phase 4
20Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)Unknown statusNCT01822418Phase 4
21Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label StudyUnknown statusNCT00708396Phase 4
22Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled StudyUnknown statusNCT01133080Phase 4
23Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With SchizophreniaUnknown statusNCT00838032Phase 4
24Identifying Predictors of Response to Antipsychotics Using a Treatment AlgorithmUnknown statusNCT01016145Phase 4
25Optimization of Acute Treatment in First Episode SchizophreniaUnknown statusNCT00157378Phase 4
26Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeUnknown statusNCT01078870Phase 4
27Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus RisperidoneUnknown statusNCT00480844Phase 4
28The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialUnknown statusNCT00468533Phase 4
29Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) ScanningUnknown statusNCT00937261Phase 4
30Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)Unknown statusNCT01250847Phase 4
31A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum DisordersUnknown statusNCT01742390Phase 4
32Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and QuetiapineUnknown statusNCT01047215Phase 4
33Donepezil Double Blind Trial for ECT Memory DisfunctionUnknown statusNCT00465283Phase 4
34Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute PsychiatryUnknown statusNCT00986167Phase 4
35Investigator Initiated Study - Asenapine Early PsychosisUnknown statusNCT01968161Phase 4
36Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaUnknown statusNCT00541554Phase 4
37A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar DisorderUnknown statusNCT00837343Phase 4
38Reduction of Cardiovascular Risk in Severe Mental IllnessUnknown statusNCT01182012Phase 4
39Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized TrialUnknown statusNCT00260390Phase 4
40Estrogen and Perimenopausal DepressionUnknown statusNCT00229450Phase 4
41Tolerance and Effect of Antipsychotics in Children and Adolescents With PsychosisUnknown statusNCT01119014Phase 4
42Treatment of Alcohol Dependence and Comorbid Bipolar DisorderUnknown statusNCT01015586Phase 4
43Ziprasidone vs Standard Therapy for Agitated Patients in the EDUnknown statusNCT00786318Phase 4
44The Effects of Nicotine on Cognition in SchizophreniaCompletedNCT00383747Phase 4
45A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With AntipsychoticsCompletedNCT02712463Phase 4
46Assertive Community Treatment (ACT) in Schizophrenia Spectrum DisordersCompletedNCT01081418Phase 4
47Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone PalmitateCompletedNCT02532842Phase 4
48Evaluation of Mirtazapine and Folic Acid for Schizophrenia:CompletedNCT01263080Phase 4
49Risperidone Maintenance Treatment in SchizophreniaCompletedNCT00848432Phase 4
50Folate Supplementation in SchizophreniaCompletedNCT00249288Phase 4

Search NIH Clinical Center for Schizophrenia

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: schizophrenia

Genetic Tests for Schizophrenia

About this section

Genetic tests related to Schizophrenia:

id Genetic test Affiliating Genes
1 Schizophrenia27 24 TAAR6
2 Schizophrenia 927
3 Schizophrenia 627

Anatomical Context for Schizophrenia

About this section

MalaCards organs/tissues related to Schizophrenia:

36
Brain, Cortex, Prefrontal cortex, Testes, Cingulate cortex, Eye, Temporal lobe

Publications for Schizophrenia

About this section

Articles related to Schizophrenia:

(show top 50)    (show all 6900)
idTitleAuthorsYear
1
Examining methods, messengers and behavioural theories to disseminate physical activity information to individuals with a diagnosis of schizophrenia: a scoping review. (28084841)
2017
2
Clinical Correlates of Treatment Response among Patients with Schizophrenia in a Tertiary Nigerian Hospital. (28529220)
2017
3
5-HT1A C-1019G (rs6295) Predicts Aripiprazole Treatment Response Specifically for Cognitive and Depressive Symptoms in Schizophrenia. (28027114)
2017
4
The impact of a TV report in schizophrenia stigma reduction: A quasi-experimental study. (28084154)
2017
5
Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study. (28464965)
2017
6
Judgment of moral and social transgression in schizophrenia. (28531645)
2017
7
A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia. (28203040)
2017
8
Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials. (28528597)
2017
9
The Effect of Cognitive Remediation Therapy on Social Skills in Institutionalized Elderly Patients with Schizophrenia. (28530532)
2017
10
Concurrent validity of Indian Disability Evaluation and Assessment Scale with sociooccupational functioning scale in patients with schizophrenia. (28529369)
2017
11
Socio-Demographic Characteristics, Partner Characteristics, Socioeconomic Variables, and Intimate Partner Violence in Women with Schizophrenia in South-South Nigeria. (28529219)
2017
12
Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research. (28508277)
2017
13
Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12A years follow-up. (28088223)
2017
14
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia. (28085950)
2017
15
Effect of childhood trauma on cognitive functions in a sample of Chinese patients with schizophrenia. (28528230)
2017
16
Aberrant spontaneous neural activity and correlation with evoked-brain potentials in first-episode, treatment-naA^ve patients with deficit and non-deficit schizophrenia. (28092779)
2017
17
White matter connectivity disruptions in early and chronic schizophrenia. (28528586)
2017
18
The Cost of Relapse in Schizophrenia. (28534254)
2017
19
Association of the IFN-I^ (+874A/T) Genetic Polymorphism with Paranoid Schizophrenia in Tunisian Population. (27819519)
2017
20
A Comparative Study Of Short Term Efficacy Of Aripiprazole And Risperidone In Schizophrenia. (28088913)
2017
21
Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia. (27523502)
2017
22
GRIN3B missense mutation as an inherited risk factor for schizophrenia: whole-exome sequencing in a family with a familiar history of psychotic disorders. (28132660)
2017
23
Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics. (28214564)
2017
24
Bipolar I disorder in remission vs. schizophrenia in remission: Is there a difference in burden? (27816846)
2017
25
Representativeness of clinical PET study participants with schizophrenia: A systematic review. (28088727)
2017
26
Short communication: Genetic association between schizophrenia and cannabis use. (28086176)
2017
27
Genetic risk for schizophrenia and psychosis in Alzheimer disease. (28461698)
2017
28
Hippocampal-prefrontal connectivity as a translational phenotype for schizophrenia. (28089652)
2017
29
Long noncoding RNA as an indicator differentiating schizophrenia from major depressive disorder and generalized anxiety disorder in nonpsychiatric hospital. (28092449)
2017
30
Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker. (27412497)
2017
31
Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia. (28532686)
2017
32
Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population. (28332369)
2017
33
Schizophrenia-like symptoms in a patient with Leigh syndrome. (28262162)
2017
34
Identification of genetic loci shared between schizophrenia and the Big Five personality traits. (28533504)
2017
35
An Association Between Functional Polymorphisms of the Interleukin 1 Gene Complex and Schizophrenia Using Transmission Disequilibrium Test. (28083609)
2017
36
Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies. (28225484)
2017
37
Neuregulin-1 mutant Mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model. (28089851)
2017
38
Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: A comparative voxel-based meta-analysis. (28082140)
2017
39
Reelin (RELN) DNA methylation in the peripheral blood of schizophrenia. (28086126)
2017
40
Association of Polymorphisms of the Receptor for Advanced Glycation Endproducts Gene with Schizophrenia in a Han Chinese Population. (28373983)
2017
41
Meta-analysis of polymorphism rs6311 and rs6313 in the 5-HT2AR gene and schizophrenia. (27598719)
2017
42
Phenotypic continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of Social Cognition (MASC). (28089135)
2017
43
Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia. (28534294)
2017
44
Following Instructions in Patients With Schizophrenia: The Benefits of Actions at Encoding and Recall. (28531307)
2017
45
Wisconsin Card Sorting Test performance impairment in schizophrenia: An Indian study report. (28529366)
2017
46
Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls. (28091349)
2017
47
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review. (28086761)
2017
48
HDAC1 links early life stress to schizophrenia-like phenotypes. (28533418)
2017
49
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. (28087270)
2017
50
Towards the recovery of a sense of self: An interpretative phenomenological analysis of patients' experience of body-oriented psychotherapy for schizophrenia. (28532254)
2017

Variations for Schizophrenia

About this section

Clinvar genetic disease variations for Schizophrenia:

5 (show all 134)
id Gene Variation Type Significance SNP ID Assembly Location
1DPYD; DPYD-AS2NC_ 000001.11: g.(?_ 97754673)_ (97877131_ ?)deldeletionLikely pathogenicNCBI36Chr 1, 97992817: 98115275
2NC_ 000001.9: g.(?_ 144100334)_ (144643106_ ?)deldeletionLikely pathogenicNCBI36Chr 1, 144100334: 144643106
3NC_ 000001.9: g.(?_ 144100334)_ (144605947_ ?)deldeletionLikely pathogenicNCBI36Chr 1, 144100334: 144605947
4NC_ 000001.9: g.(?_ 144108801)_ (144722446_ ?)dupduplicationLikely pathogenicNCBI36Chr 1, 144108801: 144722446
5NC_ 000001.9: g.(?_ 144461364)_ (146362307_ ?)deldeletionPathogenicNCBI36Chr 1, 144461364: 146362307
6NC_ 000001.9: g.(?_ 144473958)_ (146362307_ ?)deldeletionPathogenicNCBI36Chr 1, 144473958: 146362307
7CHRM3NC_ 000001.11: g.(?_ 239538135)_ (239561121_ ?)deldeletionLikely pathogenicNCBI36Chr 1, 237768058: 237791044
8subset of 12 genes:MYCNNC_ 000002.11: g.(?_ 11326144)_ (16240708_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 11243595: 16158159
9NRXN1NC_ 000002.12: g.(?_ 50722330)_ (50939855_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 50802972: 51020497
10B3GNT2; CCT4; COMMD1; FAM161A; MIR5192; SNORA70B; TMEM17; USP34; XPO1NC_ 000002.12: g.(?_ 61374256)_ (62493432_ ?)dupduplicationLikely pathogenicNCBI36Chr 2, 61454895: 62574071
11covers 19 genes, none of which curated to show dosage sensitivityNC_ 000002.11: g.(?_ 96738407)_ (97742073_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 96102134: 97105800
12CD8B2; GACAT1; LINC01789; LINC01885; LINC01886; PLGLA; RGPD3; ST6GAL2NC_ 000002.12: g.(?_ 106287425)_ (107812162_ ?)dupduplicationLikely pathogenicNCBI36Chr 2, 106270313: 107795050
13CD8B2; GACAT1; LINC01789; LINC01885; LINC01886; RGPD4-AS1; ST6GAL2NC_ 000002.12: g.(?_ 106480385)_ (107825992_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 106463273: 107808880
14AMER3; ARHGEF4; FAM168B; PLEKHB2; POTEINC_ 000002.12: g.(?_ 130731289)_ (131159370_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 131205332: 131633413
15MBD5; ORC4NC_ 000002.12: g.(?_ 147994620)_ (148348158_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 148468659: 148822197
16MBD5NC_ 000002.12: g.(?_ 148142676)_ (148241722_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 148616715: 148715761
17MBD5NC_ 000002.12: g.(?_ 148159194)_ (148220059_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 148633233: 148694098
18MBD5NC_ 000002.12: g.(?_ 148216217)_ (148405416_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 148690256: 148879455
19ZNF804ANC_ 000002.12: g.(?_ 184836884)_ (184878387_ ?)deldeletionLikely pathogenicNCBI36Chr 2, 185409856: 185451359
20ULK4NC_ 000003.11: g.(?_ 41656074)_ (41842202_ ?)deldeletionLikely pathogenicNCBI36Chr 3, 41631078: 41817206
21ULK4NC_ 000003.12: g.(?_ 41769857)_ (41857229_ ?)deldeletionLikely pathogenicNCBI36Chr 3, 41786353: 41873725
22LINC02010; LOC440982; ZIC1; ZIC4NC_ 000003.12: g.(?_ 146761458)_ (147928224_ ?)deldeletionLikely pathogenicNCBI36Chr 3, 147961935: 149128701
23subset of 32 genes:PAK2NC_ 000003.12: g.(?_ 196011149)_ (197606127_ ?)deldeletionPathogenicNCBI36Chr 3, 197222417: 198817395
24NC_ 000004.10: g.(?_ 39053592)_ (42081810_ ?)dupduplicationLikely pathogenicNCBI36Chr 4, 39053592: 42081810
25GRID2NC_ 000004.12: g.(?_ 92933574)_ (93091359_ ?)deldeletionLikely pathogenicNCBI36Chr 4, 94073748: 94231533
26NC_ 000006.10: g.(?_ 152969177)_ (154861420_ ?)dupduplicationLikely pathogenicNCBI36Chr 6, 152969177: 154861420
27PRKNNC_ 000006.12: g.(?_ 161938086)_ (162057600_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162279108: 162398622
28PRKNNC_ 000006.12: g.(?_ 161969162)_ (162291817_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162310184: 162632839
29PRKNNC_ 000006.12: g.(?_ 162146194)_ (162225195_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162487216: 162566217
30PRKNNC_ 000006.12: g.(?_ 162166741)_ (162286579_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162507763: 162627601
31PRKNNC_ 000006.12: g.(?_ 162196210)_ (162319361_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162537232: 162660383
32PRKNNC_ 000006.12: g.(?_ 162207929)_ (162418045_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162548951: 162759067
33PRKNNC_ 000006.12: g.(?_ 162214214)_ (162378344_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162555236: 162719366
34PRKNNC_ 000006.12: g.(?_ 162261451)_ (162524251_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162602473: 162865273
35PRKNNC_ 000006.12: g.(?_ 162266369)_ (162427942_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162607391: 162768964
36PRKNNC_ 000006.12: g.(?_ 162269073)_ (162300745_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162610095: 162641767
37PRKNNC_ 000006.12: g.(?_ 162291817)_ (162557106_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162632839: 162898128
38PRKNNC_ 000006.12: g.(?_ 162310185)_ (162626044_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162651207: 162967066
39PRKNNC_ 000006.12: g.(?_ 162336301)_ (162494561_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162677323: 162835583
40PACRG; PRKNNC_ 000006.12: g.(?_ 162611406)_ (162811496_ ?)deldeletionLikely pathogenicNCBI36Chr 6, 162952428: 163152518
41NC_ 000007.12: g.(?_ 72365915)_ (73776177_ ?)dupduplicationPathogenicNCBI36Chr 7, 72365915: 73776177
42CACNA2D1; HGF; LOC100128317; LOC101927356; LOC105369146; PCLO; SEMA3A; SEMA3ENC_ 000007.14: g.(?_ 81485635)_ (84094822_ ?)deldeletionLikely pathogenicNCBI36Chr 7, 80952887: 83562074
43LOC101927870; RELNNC_ 000007.14: g.(?_ 103491957)_ (103503126_ ?)deldeletionLikely pathogenicNCBI36Chr 7, 102919640: 102930809
44DOCK4; IFRD1; IMMP2L; LRRN3; LSMEM1; TMEM168; ZNF277NC_ 000007.13: g.(?_ 110151471)_ (112422581_ ?)dupduplicationLikely pathogenicNCBI36Chr 7, 109938707: 112209817
45VIPR2NC_ 000007.13: g.(?_ 158758539)_ (158988677_ ?)dupduplicationLikely pathogenicNCBI36Chr 7, 158451300: 158681438
46NC_ 000008.9: g.(?_ 2573916)_ (4761131_ ?)deldeletionLikely pathogenicNCBI36Chr 8, 2573916: 4761131
47CSMD1NC_ 000008.11: g.(?_ 3409832)_ (3514184_ ?)deldeletionLikely pathogenicNCBI36Chr 8, 3254762: 3359114
48CSMD1NC_ 000008.11: g.(?_ 3873830)_ (3956386_ ?)deldeletionLikely pathogenicNCBI36Chr 8, 3718760: 3801316
49CSMD1NC_ 000008.11: g.(?_ 3881783)_ (3956386_ ?)deldeletionLikely pathogenicNCBI36Chr 8, 3726713: 3801316
50VPS13BNC_ 000008.11: g.(?_ 99057631)_ (99225625_ ?)deldeletionLikely pathogenicNCBI36Chr 8, 100139035: 100307029
51covers 35 genes, none of which curated to show dosage sensitivityNC_ 000009.11: g.(?_ 102339410)_ (109549354_ ?)deldeletionLikely pathogenicNCBI36Chr 9, 101379231: 108589175
52ASTN2; TRIM32NC_ 000009.12: g.(?_ 116636278)_ (116741811_ ?)deldeletionLikely pathogenicNCBI36Chr 9, 118438378: 118543911
53ASTN2; TRIM32NC_ 000009.12: g.(?_ 116690492)_ (116873346_ ?)deldeletionLikely pathogenicNCBI36Chr 9, 118492592: 118675446
54ASTN2; TRIM32NC_ 000009.12: g.(?_ 116690492)_ (116732787_ ?)deldeletionLikely pathogenicNCBI36Chr 9, 118492592: 118534887
55NC_ 000010.9: g.(?_ 3110676)_ (6286817_ ?)dupduplicationLikely pathogenicNCBI36Chr 10, 3110676: 6286817
56NC_ 000010.9: g.(?_ 46383972)_ (51402930_ ?)dupduplicationLikely pathogenicNCBI36Chr 10, 46383972: 51402930
57DLG2NC_ 000011.10: g.(?_ 84115689)_ (84645962_ ?)deldeletionLikely pathogenicNCBI36Chr 11, 83504380: 84034653
58DLG2NC_ 000011.9: g.(?_ 84525944)_ (84693279_ ?)deldeletionLikely pathogenicNCBI36Chr 11, 84203592: 84370927
59DLG2NC_ 000011.10: g.(?_ 84879064)_ (84961400_ ?)deldeletionLikely pathogenicNCBI36Chr 11, 84267756: 84350092
60NC_ 000011.8: g.(?_ 118369519)_ (134444816_ ?)dupduplicationLikely pathogenicNCBI36Chr 11, 118369519: 134444816
61CACNA1C; CACNA1C-AS1NC_ 000012.12: g.(?_ 2689684)_ (2732352_ ?)deldeletionLikely pathogenicNCBI36Chr 12, 2669111: 2711779
62C1QTNF9; C1QTNF9B; MIPEP; PCOTH; SACS; SGCG; SPATA13; TNFRSF19NC_ 000013.10: g.(?_ 23544669)_ (24893183_ ?)deldeletionLikely pathogenicNCBI36Chr 13, 22442669: 23791183
63NPAS3NC_ 000014.9: g.(?_ 33322195)_ (33377295_ ?)deldeletionLikely pathogenicNCBI36Chr 14, 32861152: 32916252
64NRXN3NC_ 000014.9: g.(?_ 78888008)_ (79194197_ ?)deldeletionLikely pathogenicNCBI36Chr 14, 78424104: 78730293
65NC_ 000015.8: g.(?_ 20214229)_ (20737623_ ?)deldeletionPathogenicNCBI36Chr 15, 20214229: 20737623
66NC_ 000015.8: g.(?_ 20214229)_ (20690583_ ?)deldeletionPathogenicNCBI36Chr 15, 20214229: 20690583
67NC_ 000015.8: g.(?_ 20311080)_ (20672108_ ?)deldeletionPathogenicNCBI36Chr 15, 20311080: 20672108
68NC_ 000015.8: g.(?_ 20311080)_ (20636781_ ?)deldeletionPathogenicNCBI36Chr 15, 20311080: 20636781
69NC_ 000015.8: g.(?_ 20311080)_ (20747796_ ?)deldeletionPathogenicNCBI36Chr 15, 20311080: 20747796
70NC_ 000015.8: g.(?_ 20311080)_ (20737623_ ?)deldeletionPathogenicNCBI36Chr 15, 20311080: 20737623
71NC_ 000015.8: g.(?_ 21144837)_ (26726521_ ?)dupduplicationPathogenicNCBI36Chr 15, 21144837: 26726521
72NC_ 000015.8: g.(?_ 26866219)_ (28542654_ ?)deldeletionLikely pathogenicNCBI36Chr 15, 26866219: 28542654
73NC_ 000015.8: g.(?_ 26866219)_ (28153380_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 26866219: 28153380
74APBA2; CHRFAM7A; FAM189A1; GOLGA8J; NSMCE3; TJP1NC_ 000015.9: g.(?_ 29220618)_ (30679040_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 27007910: 28466332
75APBA2; CHRFAM7A; FAM189A1; GOLGA8J; NSMCE3; TJP1NC_ 000015.9: g.(?_ 29220618)_ (30664963_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 27007910: 28452255
76ARHGAP11B; CHRNA7; FAN1; GOLGA8H; KLF13; MIR211; MTMR10; OTUD7A; TRPM1NC_ 000015.9: g.(?_ 30882901)_ (32439053_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 28670193: 30226345
77CHRNA7NC_ 000015.9: g.(?_ 32024200)_ (32439053_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 29811492: 30226345
78CHRNA7NC_ 000015.9: g.(?_ 32024200)_ (32548462_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 29811492: 30335754
79CHRNA7NC_ 000015.9: g.(?_ 32029601)_ (32655281_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 29816893: 30442573
80NC_ 000015.8: g.(?_ 72171336)_ (75954661_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 72171336: 75954661
81covers 13 genes, none of which curated to show dosage sensitivityNC_ 000015.9: g.(?_ 100885379)_ (102399948_ ?)dupduplicationLikely pathogenicNCBI36Chr 15, 98702902: 100217471
82CACNA1H; TPSAB1; TPSB2; TPSG1NC_ 000016.9: g.(?_ 1239945)_ (1300070_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 1179946: 1240071
83RBFOX1NC_ 000016.10: g.(?_ 6632442)_ (7019814_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 6622444: 7009816
84RBFOX1NC_ 000016.10: g.(?_ 6664640)_ (6742835_ ?)deldeletionLikely pathogenicGRCh38Chr 16, 6664640: 6742835
85RBFOX1NC_ 000016.10: g.(?_ 7038520)_ (7097699_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 7028522: 7087701
86covers 25 genes, none of which curated to show dosage sensitivityNC_ 000016.10: g.(?_ 15031901)_ (16512853_ ?)dupduplicationPathogenicNCBI36Chr 16, 15033259: 16514211
87covers 13 genes, none of which curated to show dosage sensitivityNC_ 000016.9: g.(?_ 15180601)_ (18778866_ ?)dupduplicationPathogenicNCBI36Chr 16, 15088102: 18686367
88covers 12 genes, none of which curated to show dosage sensitivityNC_ 000016.10: g.(?_ 15318653)_ (16292712_ ?)dupduplicationPathogenicNCBI36Chr 16, 15320011: 16294070
89covers 19 genes, none of which curated to show dosage sensitivityNC_ 000016.10: g.(?_ 15330513)_ (16443434_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 15331871: 16444792
90C16orf52; CDR2; EEF2K; PDZD9; POLR3E; SDR42E2; TRL-AAG2-4; TRL-TAG3-1; UQCRC2; VWA3ANC_ 000016.10: g.(?_ 21939023)_ (22424261_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 21857845: 22343083
91C16orf52; CDR2; EEF2K; PDZD9; POLR3E; SDR42E2; TRL-AAG2-4; TRL-TAG3-1; UQCRC2; VWA3ANC_ 000016.10: g.(?_ 21939023)_ (22434144_ ?)dupduplicationLikely pathogenicNCBI36Chr 16, 21857845: 22352966
92subset of 25 genes:SH2B1NC_ 000016.10: g.(?_ 28370872)_ (29324276_ ?)deldeletionLikely pathogenicNCBI36Chr 16, 28289694: 29243098
93subset of 28 genes:PRRT2NC_ 000016.10: g.(?_ 29620718)_ (30181241_ ?)dupduplicationPathogenicNCBI36Chr 16, 29539540: 30100063
94subset of 28 genes:PRRT2NC_ 000016.10: g.(?_ 29634955)_ (30181241_ ?)dupduplicationPathogenicNCBI36Chr 16, 29553777: 30100063
95subset of 28 genes:PRRT2NC_ 000016.10: g.(?_ 29634955)_ (30181241_ ?)deldeletionLikely pathogenicGRCh37Chr 16, 29646276: 30192562
96subset of 28 genes:PRRT2NC_ 000016.10: g.(?_ 29646068)_ (30181241_ ?)dupduplicationPathogenicNCBI36Chr 16, 29564890: 30100063
97CDRT15; CDRT4; COX10; HS3ST3B1; PMP22; TEKT3; TVP23C; TVP23C-CDRT4NC_ 000017.10: g.(?_ 14083471)_ (15420108_ ?)deldeletionLikely pathogenicNCBI36Chr 17, 14024196: 15360833
98PTPRMNC_ 000018.10: g.(?_ 7776842)_ (8247510_ ?)deldeletionLikely pathogenicNCBI36Chr 18, 7766840: 8237508
99KATNAL2NC_ 000018.10: g.(?_ 47048374)_ (47074966_ ?)deldeletionLikely pathogenicNCBI36Chr 18, 42828743: 42855335
100NC_ 000019.8: g.(?_ 46811356)_ (49506179_ ?)dupduplicationLikely pathogenicNCBI36Chr 19, 46811356: 49506179
101NC_ 000022.9: g.(?_ 17024062)_ (20056851_ ?)deldeletionPathogenicNCBI36Chr 22, 17024062: 20056851
102NC_ 000022.9: g.(?_ 17024062)_ (20037371_ ?)deldeletionPathogenicNCBI36Chr 22, 17024062: 20037371
103NC_ 000022.9: g.(?_ 17024062)_ (20087703_ ?)deldeletionPathogenicNCBI36Chr 22, 17024062: 20087703
104NC_ 000022.9: g.(?_ 17025596)_ (19365543_ ?)deldeletionPathogenicNCBI36Chr 22, 17025596: 19365543
105NC_ 000022.9: g.(?_ 17176197)_ (20026630_ ?)deldeletionPathogenicNCBI36Chr 22, 17176197: 20026630
106NC_ 000022.9: g.(?_ 17201569)_ (19790598_ ?)deldeletionPathogenicNCBI36Chr 22, 17201569: 19790598
107NC_ 000022.9: g.(?_ 17227336)_ (19896035_ ?)deldeletionPathogenicNCBI36Chr 22, 17227336: 19896035
108NC_ 000022.9: g.(?_ 17269529)_ (19790598_ ?)deldeletionPathogenicNCBI36Chr 22, 17269529: 19790598
109NC_ 000022.9: g.(?_ 17269529)_ (19365543_ ?)deldeletionPathogenicNCBI36Chr 22, 17269529: 19365543
110NC_ 000022.9: g.(?_ 17269529)_ (18691906_ ?)deldeletionPathogenicNCBI36Chr 22, 17269529: 18691906
111NC_ 000022.9: g.(?_ 18871966)_ (19825156_ ?)deldeletionLikely pathogenicNCBI36Chr 22, 18871966: 19825156
112covers 15 genes, none of which curated to show dosage sensitivityNC_ 000022.10: g.(?_ 20721034)_ (21460598_ ?)deldeletionLikely pathogenicNCBI36Chr 22, 19051034: 19790598
113TOP3BNC_ 000022.10: g.(?_ 22320930)_ (22566160_ ?)deldeletionLikely pathogenicNCBI36Chr 22, 20650930: 20896160
114subset of 36 genes:SMARCB1NC_ 000022.10: g.(?_ 22971580)_ (25041986_ ?)dupduplicationLikely pathogenicNCBI36Chr 22, 21301580: 23371986
115subset of 27 genes:SMARCB1NC_ 000022.10: g.(?_ 23667751)_ (24991609_ ?)dupduplicationLikely pathogenicNCBI36Chr 22, 21997751: 23321609
116subset of 28 genes:SMARCB1NC_ 000022.10: g.(?_ 23667751)_ (25041986_ ?)dupduplicationLikely pathogenicNCBI36Chr 22, 21997751: 23371986
117NC_ 000023.9: g.(?_ 1)_ (154913754_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 1: 154913754
118NC_ 000023.9: g.(?_ 6329)_ (8342481_ ?)deldeletionLikely pathogenicNCBI36Chr X, 6329: 8342481
119MIR4767; MIR651; PNPLA4; PUDP; STS; VCX; VCX3ANC_ 000023.11: g.(?_ 6528271)_ (8167329_ ?)deldeletionLikely pathogenicNCBI36Chr X, 6456312: 8095370
120MIR4767; MIR651; PNPLA4; PUDP; STS; VCX; VCX3ANC_ 000023.11: g.(?_ 6528271)_ (8151196_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 6456312: 8079237
121MIR4767; MIR651; PNPLA4; PUDP; STS; VCXNC_ 000023.11: g.(?_ 6535136)_ (8151196_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 6463177: 8079237
122MIR4767; MIR651; PNPLA4; PUDP; STS; VCXNC_ 000023.11: g.(?_ 6538718)_ (8151196_ ?)deldeletionLikely pathogenicNCBI36Chr X, 6466759: 8079237
123MIR4767; MIR651; PNPLA4; PUDP; STS; VCXNC_ 000023.11: g.(?_ 6538718)_ (8151196_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 6466759: 8079237
124MIR4767; PUDP; STSNC_ 000023.11: g.(?_ 6768943)_ (7796577_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 6696984: 7724618
125MIR4767; PNPLA4; PUDP; STS; VCXNC_ 000023.11: g.(?_ 6780568)_ (7922451_ ?)deldeletionLikely pathogenicNCBI36Chr X, 6708609: 7850492
126DMDNC_ 000023.11: g.(?_ 31776993)_ (31852470_ ?)deldeletionLikely pathogenicNCBI36Chr X, 31705031: 31780508
127NC_ 000023.9: g.(?_ 109211561)_ (114336714_ ?)dupduplicationLikely pathogenicNCBI36Chr X, 109211561: 114336714
128TMLHENC_ 000023.11: g.(?_ 155532402)_ (155554623_ ?)deldeletionLikely pathogenicGRCh37Chr X, 154762063: 154784284
129NC_ 000023.9: g.(?_ 154535668)_ (154840791_ ?)deldeletionLikely pathogenicNCBI36Chr X, 154535668: 154840791
130SETD1ANM_ 014712.2(SETD1A): c.518-2A> GSNVPathogenicrs869312829GRCh37Chr 16, 30974752: 30974752
131SETD1ANM_ 014712.2(SETD1A): c.1272delC (p.Tyr425Thrfs)deletionPathogenicrs869312830GRCh37Chr 16, 30976335: 30976335
132SETD1ANM_ 014712.2(SETD1A): c.2209C> T (p.Gln737Ter)SNVPathogenicrs869312831GRCh37Chr 16, 30977411: 30977411
133SETD1ANM_ 014712.2(SETD1A): c.2171dupC (p.Ala725Serfs)duplicationPathogenicrs869312832GRCh38Chr 16, 30966052: 30966052
134SETD1ANM_ 014712.2(SETD1A): c.1938C> G (p.Tyr646Ter)SNVPathogenicrs770913157GRCh37Chr 16, 30977140: 30977140

Copy number variations for Schizophrenia from CNVD:

6 (show top 50)    (show all 5299)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1133681116700000DeletionSchizophrenia
213397112300000GainOR4F16Schizophrenia
313398112300000GainOR4F29Schizophrenia
413399112300000GainOR4F3Schizophrenia
513400112300000GainOR4F5Schizophrenia
61373711247249719DeletionSchizophrenia
713808116300000Copy numberSchizophrenia
8139971102428272102625426DeletionSchizophrenia
9140011102628520102630703DeletionSchizophrenia
10140841103900163104069733DuplicationSchizophrenia
11140851103904299104069733DuplicationSchizophrenia
12141021103957313104069733DeletionSchizophrenia
13141031103957313104069733DuplicationSchizophrenia
14141051103958672104069733DeletionSchizophrenia
15141061103959820104069733DeletionSchizophrenia
16141071103960858104069733DeletionSchizophrenia
17143351107200000111800000Copy numberSchizophrenia
18144501108512791108702882DeletionSchizophrenia
1915499111612321266721DeletionSchizophrenia
20159501120437237120490996DuplicationSchizophrenia
21159941120870371121045604DuplicationSchizophrenia
221656411276843812920855DeletionSchizophrenia
231656511276843813081658DeletionSchizophrenia
241656611276843813304227DeletionSchizophrenia
251657611277533512920855DeletionSchizophrenia
26172801142400000148000000Copy numberSchizophrenia
27172811142400000148000000Copy numberSchizophrenia
28172871142400000148000000DeletionSchizophrenia
29172881142400000148000000DeletionSchizophrenia
30172891142400000148000000DeletionSchizophrenia
31172901142400000148000000DeletionSchizophrenia
32172911142400000148000000DeletionSchizophrenia
33172921142400000148000000DeletionSchizophrenia
34173111142400000148000000GainFCGR1ASchizophrenia
35173131142400000148000000GainHIST2H2BFSchizophrenia
36173151142400000148000000GainPPIAL4Schizophrenia
37173311142400000148000000MicroduplicationSchizophrenia
38173581142557948142697860DuplicationSchizophrenia
39173731142600000147000000Copy numberSchizophrenia
40173791142600000147000000DeletionSchizophrenia
41173801142600000147000000DeletionSchizophrenia
42173811142600000147000000DeletionSchizophrenia
43173821142600000147000000DeletionSchizophrenia
44173861142600000147000000Deletion or duplicationSchizophrenia
45173941142600000155000000DeletionSchizophrenia
46174441142803849143666594DuplicationSchizophrenia
47181221144106312146292286DeletionSchizophrenia
48181231144106312146293282DeletionSchizophrenia
49181291144149818144153985Copy numberTXNIPSchizophrenia
50181371144188441144210448GainLIX1LSchizophrenia

Expression for genes affiliated with Schizophrenia

About this section
Search GEO for disease gene expression data for Schizophrenia.

Pathways for genes affiliated with Schizophrenia

About this section

Pathways related to Schizophrenia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
10.8DRD2, DRD3, HTR2A, TAAR6

GO Terms for genes affiliated with Schizophrenia

About this section

Cellular components related to Schizophrenia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axonGO:003042411.6COMT, DISC1, DRD2, DTNBP1, HTR2A, NRG1
2postsynaptic densityGO:001406911.4DISC1, DRD2, DTNBP1, SYN2
3cell bodyGO:004429711.4COMT, DISC1, NRG1
4dendritic spineGO:004319711.4COMT, DRD2, DTNBP1
5synapseGO:004520211.3DISC1, DTNBP1, MTHFR, NRG1, SYN2
6synaptic vesicle membraneGO:003067210.7DRD2, DTNBP1, SYN2

Biological processes related to Schizophrenia according to GeneCards Suite gene sharing:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1regulation of dopamine secretionGO:001405911.4DRD2, DRD3, DTNBP1, HTR2A
2behavioral response to cocaineGO:004814811.4DRD2, DRD3, HTR2A
3dopamine metabolic processGO:004241711.4COMT, DRD2, DRD3
4locomotory behaviorGO:000762611.3DRD2, DRD3, NRG1
5response to drugGO:004249311.3COMT, DRD2, DRD3, HTR2A, MTHFR
6acid secretionGO:004671711.3DRD2, DRD3
7adenylate cyclase-inhibiting dopamine receptor signaling pathwayGO:000719511.3DRD2, DRD3
8dopamine receptor signaling pathwayGO:000721211.3DRD2, DRD3
9G-protein coupled receptor internalizationGO:000203111.3DRD2, DRD3
10negative regulation of dopamine receptor signaling pathwayGO:006016011.3DRD2, DRD3
11negative regulation of protein secretionGO:005070911.3DRD2, DRD3
12negative regulation of synaptic transmission, glutamatergicGO:005196711.3DRD2, HTR2A
13positive regulation of neuroblast proliferationGO:000205211.3DISC1, DRD2
14positive regulation of renal sodium excretionGO:003581511.3DRD2, DRD3
15prepulse inhibitionGO:006013411.3DRD2, DRD3
16regulation of cAMP metabolic processGO:003081411.3DRD2, DRD3
17proline catabolic processGO:000656211.3DAO, PRODH
18regulation of dopamine uptake involved in synaptic transmissionGO:005158411.2DRD2, DRD3
19regulation of locomotion involved in locomotory behaviorGO:009032511.2DRD2, DRD3
20response to histamineGO:003477611.1DRD2, DRD3
21startle responseGO:000196411.0DRD2, NRG1
22synaptic transmission, dopaminergicGO:000196311.0DRD2, DRD3
23temperature homeostasisGO:000165910.6DRD2, HTR2A

Molecular functions related to Schizophrenia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dopamine bindingGO:003524011.1DRD2, DRD3
2dopamine neurotransmitter receptor activityGO:000495211.1DRD2, DRD3
3dopamine neurotransmitter receptor activity, coupled via Gi/GoGO:000159111.1DRD2, DRD3
4drug bindingGO:000814411.0DRD2, DRD3, HTR2A
5FAD bindingGO:007194910.6DAO, PRODH

Sources for Schizophrenia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet